BBOT

BridgeBio Oncology
BBOT

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $167M invested in BridgeBio Oncology in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $
Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.82M
2
+$1.48M
3
+$119K
4
Walleye Capital
Walleye Capital
New York
+$6.54K
5
ACM
ADAR1 Capital Management
Texas
+$6.52K

Top Sellers

1
-$179K
2
-$39.9K
3
-$35.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$29.7M
2
$15.3M
3
$14.3M
4
$13.6M
5
$11.6M
6
$11.4M
7
$7.21M
8
$6.13M
9
$5.11M
10
$5.11M
11
$5.11M
12
$5.11M
13
$4.85M
14
$4.13M
15
$4.09M
16
$3.07M
17
$3.07M
18
$2.56M
19
$2.56M
20
$2.04M
21
$1.93M
22
$1.89M
23
$1.82M
24
$1.48M
25
$1.06M
1
2